7 completed, 1 unknown. 3 Phase 3, 3 Phase 4, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Unknown 1 |
| Phase 4 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Ticlopidine: new trials by email Literature Review of Ticlopidine trials Research Report on Ticlopidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants Esketamine, Ticlopidine - Healthy | Phase 1 | Completed | Janssen Research & Development, LLC | 16 | 2017-09-26 | 2025-04-27 |
| Clopidogrel Resistance and Embolism in Carotid Artery Stenting Ticlopidine + Ginko biloba, Clopidogrel - Carotid Stenosis | Phase 3 | Unknown | Samsung Medical Center | 86 | 2014-06-01 | 2017-04-26 |
| PROMUS Element Plus US Post-Approval Study PROMUS Element Plus Coronary Stent System, Aspirin, P2Y12 antagonist - Coronary Artery Disease | Phase 4 | Completed | Boston Scientific Corporation | 2681 | 2012-05-01 | 2018-07-26 |
| Effect of Itraconazole and Ticlopidine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol Placebo, Ticlopidine, Ticlopidine and itraconazole - Pharmacokinetics, Pharmacodynamics | Phase 4 | Completed | Turku University Hospital | 12 | 2010-09-01 | 2011-04-13 |
| Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease clopidogrel (SR25990), ticlopidine - Peripheral Arterial Disease (PAD) | Phase 3 | Completed | Sanofi | 431 | 2009-02-01 | 2012-07-17 |
| Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned clopidogrel (SR25990), ticlopidine, Placebo - Stable Angina, Myocardial Infarction | Phase 3 | Completed | Sanofi | 1003 | 2008-12-01 | 2011-07-26 |
| Aspirin Resistance and Percutaneous Coronary Intervention (PCI) Intravenous Glycoprotein inhibitor + ASA, Clopidogrel, Antiplatelet Therapy (ASA, Clopidogrel) - Stable Angina | Phase 2 | Completed | Icahn School of Medicine at Mount Sinai | 36 | 2007-04-01 | 2018-02-14 |
| Antiplatelet Therapy to Prevent Stroke in African Americans aspirin, ticlopidine - Stroke, Cerebral Infarction | Phase 4 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 2005-06-24 |
Angina, Stable (2) · Atherosclerosis (1) · Carotid Stenosis (1) · Cerebral Infarction (1) · Coronary Artery Disease (1) · Death (1) · Hemorrhage (1) · Ischemic Stroke (1) · Myocardial Infarction (1) · Peripheral Arterial Disease (1) · Stroke (1)
Sanofi (2) · Boston Scientific Corporation (1) · Icahn School of Medicine at Mount Sinai (1) · Janssen Research & Development, LLC (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Samsung Medical Center (1) · Turku University Hospital (1)
United States (3) · Japan (2) · Belgium (1) · Finland (1) · South Korea (1)
Annapoorna S Kini, MD MRCP (1) · Hiroshi Shigematsu, Head Professor/MD/PhD (1) · Klaus T Olkkola, MD, PhD, Prof (1) · Oh Young Bang, MD (1) · Peter M Maurer, MPH (1) · Philip B. Gorelick, M.D., M.P.H (1) · Takaaki Issiki, PhD/FACC (1)
PMID 23099620, PMID 23555538, PMID 26732420, PMID 30761076, PMID 33636137, PMID 37354778
2017 (1)